Behind Every Test, an Industry

Your doctor knows what your serum calcium is. Your doctor has probably never asked what your intracellular magnesium is. This is not an accident of biology.

The bloodwork returns. Calcium: normal. 25-OH-vitamin D: normal. Folate: normal. Ferritin, transferrin saturation: normal. TSH: normal. Fasting glucose: normal. This is what a “nutritional workup” looks like in most of the Western world, if you can even call it that. Five to seven markers, chosen from among the several dozen that would characterise the biochemical state of a modern adult. The question we rarely ask — because we have been trained to receive the standard panel as if it were nature — is: why these markers, and not the others?

The answer, on inspection, is not primarily technical. It is not that these particular molecules are the ones biology has singled out as most essential. It is not that the missing tests are unfeasible or unproven. The answer is that behind almost every nutrient routinely tested — or routinely fortified, or routinely promoted — stands a food industry that has organised itself around that specific molecule. And behind almost every nutrient that is missing from the panel, missing from the fortification list, missing from public consciousness, stands the absence of such an industry.

This is the pattern this piece describes. It is a companion to The Hunger We Don’t See: that piece traced the technical failures of the tests that are ordered. This one traces the economic logic that determines which tests exist at all.

The thesis

Not a conspiracy. Not an invention ex nihilo. A selection, and an amplification.

Industries do not fabricate biological priorities from nothing. Iron deficiency was recognised in antiquity; folate’s role in neural tube development was demonstrated in the early 1990s; the biology of vitamin D and calcium in bone mineralisation is not a marketing artefact. The industries did not conjure these priorities. What they did — and continue to do — is select, among the genuine biological priorities, those that align with their products, and amplify their cultural, institutional, and diagnostic centrality. Everything else is allowed to fall into the background: undertested, unfortified, unfunded, unknown.

The pattern is legible in the tests themselves. Some nutrients that pass the industrial filter get real, functioning tests (iron). Others get degraded tests — the cheapest reproducible version, adequate to sustain the message, inadequate to answer the biological question (vitamin D, folate). One gets a test that does not measure the nutrient at all, but is nevertheless universal and read as if it did (calcium). One is massively fortified but never tested (vitamin A). And a large group of biologically essential nutrients — magnesium, potassium, vitamin K2, functional B12, omega-3, zinc, iodine in the West — is neither tested nor fortified, because no organised food industry has staked its identity on them.

Five cases, in order from the honest to the paradigmatic.

1. Iron — what medicine gets right, and why

Iron is the case that must be named first, because it is the case where the medical system actually delivers. The bilan martial — ferritin, serum iron, total iron-binding capacity, transferrin saturation, sometimes soluble transferrin receptor — is a real, multi-marker functional panel. It captures stores, transport, and availability. Interpreted with a concomitant CRP to correct for the inflammatory rise of ferritin, it answers the question a physician actually needs answered: is this patient iron-deficient at the tissue level?

The biology is severe and ancient. Iron-deficiency anaemia is the most prevalent nutritional deficiency in the world, affecting roughly two billion people. It kills women in the peripartum period through haemorrhage. It permanently compromises the cognitive development of children in the first thousand days. Chlorosis of the young woman was recognised as a distinct clinical entity from antiquity; Blaud’s pill, the first oral iron supplement, was formulated in 1832 — before the modern food industry existed. The biological importance of iron did not require an industry to establish it.

What followed was a coalition of industries capitalising on a pre-existing biological reality:

• The red meat industry promoted the superiority of haem iron, funded educational materials, sponsored dietetic conferences.
• The milling and grain industry benefitted from mandatory iron fortification of wheat flour, maize meal, and rice — a policy now in force in roughly eighty-five countries. Every industrial bread, every commercial pasta, every breakfast cereal carries the iron message.
• The infant formula industry — Nestlé, Abbott, Mead Johnson — makes iron content a competitive dimension.
• The pharmaceutical industry operates a large oral supplement market and, more recently, a rapidly growing injectable market (ferric carboxymaltose, iron sucrose).

The iron case is honest in a specific sense: the industries did not need to fabricate anything. They aligned with a reality the medicine of the nineteenth century had already established. And because the biology genuinely demands it, the test was allowed to become a proper multi-marker panel rather than a single reassuring number.

The lesson is not that iron is exceptional. The lesson is that conventional medicine is capable of building a functioning nutrient test when the biological necessity and the industrial constituency align. The obstacle for magnesium, potassium, K2, functional B12 is nowhere technical. The template exists. It has existed for over a century. What is missing, for every one of those nutrients, is a constituency with iron’s political weight.

2. Vitamin D — the degraded version

Vitamin D is where the pattern begins to show its teeth. The biology is real. Deficiency contributes to rickets, osteomalacia, elevated risk of falls and fractures in older adults, immune dysregulation, all-cause mortality in the deficient tail of the distribution. It is not a marketing invention.

The industrial alignment is intense. The dairy industry has carried vitamin D as its principal health-claim vehicle since the United States made D fortification of fluid milk mandatory in 1933. Margarine fortification followed in most of Europe. Breakfast cereals, orange juice, plant milks, infant formulas — the fortification cascade now reaches almost every processed food. Endocrinology as a specialty organises itself around bone as an endpoint, and around vitamin D as a treatable lever. Downstream, the pharmaceutical industry operates markets for prescription D3, calcitriol, and paricalcitol; the supplement industry distributes over-the-counter D at scale.

The test that conventional medicine orders is 25-hydroxyvitamin D by immunoassay. It is what appears on the panel in nearly every clinic. It measures the storage form of the vitamin. It is not a bad test in the abstract — but it is a degraded version of what is technically feasible:

• Between-manufacturer immunoassay variance is on the order of 10 nmol/L or more for the same sample, well within the range that changes clinical action. A patient can be told “deficient” on one platform and “sufficient” on another.
• LC-MS/MS — liquid chromatography-tandem mass spectrometry — is the accepted gold standard, distinguishes D2 from D3, and does not suffer the cross-reactivities that undermine immunoassays. Only some large reference laboratories run it. Most clinical labs run cheaper immunoassays.
• The bioavailable fraction — free 25-OH-D plus albumin-bound — is what actually reaches the receptor. Total 25-OH-D includes the 85–90% bound to vitamin D binding protein (VDBP), which is not biologically active in the same way. Polymorphisms of VDBP (Gc1s, Gc1f, Gc2) distribute unevenly across ancestries, meaning the same total 25-OH-D reflects very different bioavailability in different individuals.
• The calculated bioavailable D — total 25-OH-D combined with VDBP and albumin measurements — is available commercially through specialty laboratories (Pan Laboratories, GrassrootsHealth blood spot programs, others), sold outside the conventional insurance system, paid by the patient.

The pattern is unmistakable: when biology is real but the industry cares primarily about the product rather than the precision of the measurement, the test settles at the cheapest reproducible version. Precision was never the point of the test. The point was to sustain a message aligned with a fortification chain and a supplement market. Better tests exist. They are sold to patients who pay for them. The medical system operates on the version that serves the industrial infrastructure.

3. Folate — the victory and its shadow

Folate is the case that most clearly demonstrates the ambivalence of the pattern. It contains a genuine, measurable, historic public health victory — and, welded to it, a systematic silence about a documented harm.

The victory: the MRC Vitamin Study (Lancet 1991) and the Czeizel & Dudás trial (NEJM 1992) established that periconceptional supplementation with folic acid reduces neural tube defects (spina bifida, anencephaly) by 70 to 85%. In 1998, the United States and Canada mandated fortification of enriched grain products with folic acid at 140 μg per 100 g of flour. Roughly eighty-five countries have since adopted mandatory fortification. Rates of NTDs dropped by 30 to 50% in North America in the years that followed. This is one of the rare unambiguous nutritional victories of the twentieth century.

The industrial winner was the milling and cereal industry. Mandatory fortification is inexpensive per unit; it confers a public health halo on an otherwise increasingly criticised category (ultra-processed refined grain); and it makes the industrial product biologically necessary — the very ubiquity of fortification is the argument for continued consumption. Secondary winners: the prenatal vitamin industry, the methylfolate supplement industry for the functional-medicine niche around MTHFR polymorphisms, and the diffuse produce lobby, which uses folate (etymologically from folium, leaf) as the biological argument for the “5 a day” campaign.

The shadow is that mandatory folic acid fortification masks vitamin B12 deficiency in older adults. B12 deficiency historically presented as megaloblastic anaemia — the same haematological picture as folate deficiency, because both nutrients participate in DNA synthesis. Folic acid at fortification-scale doses corrects the anaemia without correcting the neurological damage of B12 deficiency, which continues to progress silently. In patients with low B12, elevated serum folate is associated with a paradoxical worsening of both homocysteine and methylmalonic acid (see Folate). The population most exposed to this masking is the elderly, where B12 deficiency reaches 15–20% after age 70.

This risk has been in the literature for two decades. It is systematically minimised in official communications, because to name it is to reopen the fortification consensus — and reopening the consensus threatens the milling industry’s public health halo. B12, unlike folic acid, has no industry. Meat carries B12 but does not market itself on this basis. The functional B12 markers (holotranscobalamin, methylmalonic acid) are not routine. The masking is allowed to continue because the constituency that would raise the alarm does not exist.

The test conventional medicine uses for folate — serum folate — is itself degraded. A single meal rich in leafy greens normalises it for days. Erythrocyte folate reflects two to three months of average status and is a materially better test; it is ordered rarely. Homocysteine and methylmalonic acid, the functional markers, are essentially never ordered in general practice.

4. Calcium — the paradigmatic case

Calcium is the paradigmatic case of the thesis: weak or contested biology, a test that does not measure the nutrient, and an industrial infrastructure that carries essentially all of the cultural and diagnostic weight.

Serum calcium (total and ionised) is on every basic metabolic panel. It is one of the most frequently ordered tests in modern medicine. But what it measures is not calcium nutritional status — it is parathyroid, renal, and paraneoplastic regulation. Serum calcium is defended within an extraordinarily narrow band (roughly 2.15–2.55 mmol/L) by PTH, calcitriol, and the renal handling of calcium and phosphate. A skeletal reservoir of approximately one kilogram of calcium will be silently demineralised over years to maintain the serum value in range. A patient can be in active demineralisation for two decades and present a perfectly normal serum calcium at every visit.

The test, therefore, is genuinely useful — but for a different clinical question: it detects primary hyperparathyroidism, hypoparathyroidism, hypercalcaemia of malignancy, tumour lysis, advanced renal disease. It is a regulatory test, not a nutritional test. Yet it is culturally read as if it settled the question of dietary calcium adequacy. Patients tell each other, and are told by clinicians, that a “normal calcium” means their calcium intake is fine. It does not.

The industrial infrastructure around calcium is one of the most extensively documented in nutritional epidemiology:

• The United States Food Pyramid, then MyPlate, place dairy as a separate food group — a distinction made by no other national food guide until 2019, when Canada explicitly removed the “milk and alternatives” category after twenty years of pressure from the Dairy Farmers of Canada to maintain it.
• The Dairy Council, the Dairy Management Inc. checkoff program (US), and equivalent institutions in Canada, Europe, and Australasia have financed decades of public education and clinical guideline advocacy.
• The Dietary Reference Intakes for calcium in North America (1000–1200 mg/day for adults) are among the highest in the world. The World Health Organization sets its adequacy floor at 500 mg. Populations with historically low calcium intake (Japan, much of Asia) do not have elevated rates of osteoporotic fracture — some have lower rates than high-consumption countries. The Institute of Medicine panels that set the North American DRIs have carried documented consultant relationships with the dairy industry.
• Fortification cascade in orange juice, breakfast cereals, plant milks, tofu. Even non-dairy products carry the calcium message, and in doing so validate it: if every product must be enriched with calcium, calcium must be essential.
• Special Milk Program in US schools since 1954. School milk programs in most Canadian provinces. Generational conditioning to the equation milk = calcium = strong bones.
• Downstream pharmaceutical cascade: DEXA scanning (imaging revenue), bisphosphonates (Fosamax, Actonel, Reclast, Boniva — multi-billion dollar market), PTH analogues (Forteo, Tymlos), denosumab (Prolia), calcium + D supplements (Caltrate, Tums as dual-use antacid).
• Professional societies — endocrinology, rheumatology, gynaecology in the menopause space — organised around osteoporosis as a disease entity and around calcium as a therapeutic lever.

The paradoxes that would falsify the calcium-fracture narrative have been documented for over a decade and produce essentially no institutional response:

• Countries with the highest dairy and calcium consumption (Scandinavia, United States) have among the highest hip fracture rates in the world (Michaëlsson et al., BMJ 2014; Feskanich, Nurses’ Health Study).
• Calcium supplementation has no meaningful effect on fracture prevention in general adult populations by recent meta-analyses (Bolland et al., BMJ 2015; Zhao et al., JAMA 2017).
• Calcium supplementation isolated from vitamin D is associated with a small but real increase in cardiovascular events (Bolland et al., BMJ 2010, 2011).

Meanwhile, what actually determines bone integrity — vitamin D (partially covered), vitamin K2 (uncovered), magnesium (untested at the tissue level), potassium and dietary acid-base balance (untested), sex hormones (see Optimal Hormonal Levels), weight-bearing mechanical loading — is largely absent from the framework the calcium infrastructure has built. K2 and Mg have no industry. Neither has a routine test. Neither is on the panel.

When the biology is weak, the industry does all the work — and the test’s universality provides silent authority to a message the test does not, in fact, support.

5. Vitamin A — the industry without a test

Vitamin A occupies a category the other four cases do not: massive fortification without any routine test. It is the purest case of an industrial infrastructure circulating a product without ever asking what happens to it in the individual body.

The biology is real at the extreme. Vitamin A deficiency causes 250,000 to 500,000 cases of childhood blindness per year, concentrated in rice-monoculture regions of Asia and sub-Saharan Africa; roughly half of the affected children die within twelve months. The clinical sequence — night blindness, Bitot’s spots, xerophthalmia, corneal ulceration, keratomalacia — is well described. Deficiency dramatically increases mortality from measles.

The humanitarian response is real, and is where the industrial pattern becomes visible in a form so clean it is almost a caricature. The global program of biannual high-dose vitamin A supplementation for preschool children in low-income countries — 200,000 IU capsules distributed through UNICEF and WHO structures — was founded, structured, and largely financed by Sight and Life, a foundation created by Roche, which was for decades the dominant commercial producer of synthetic retinyl palmitate (now DSM, following corporate reorganisation). Sight and Life publishes a journal, distributes awards, sponsors research, trains field investigators. The primary commercial producer of the fortificant established the humanitarian program that canonised the deficiency as a global health priority.

This is not a conspiracy. The children going blind in Bangladesh are real. The intervention works, at least on the visual endpoint (the DEVTA trial in India, Lancet 2013, showed no effect on all-cause mortality, complicating the older estimate of a 24% mortality reduction). But the structural fact is that the world’s understanding of vitamin A deficiency as a public health priority was shaped by the entity with the largest financial interest in its continued centrality.

In the Western world, the pattern shifts. The routine serum retinol test essentially does not exist in conventional practice. No general practitioner orders it on a routine panel. The nutrient is homeostatically defended by hepatic stores, and short of severe malabsorption or advanced hepatic disease, serum values remain in range even in populations with genuinely inadequate intake. There is no routine biochemical monitoring of vitamin A status in Western adults.

And yet:

• Vitamin A fortification of fluid milk is mandatory in the United States since 1933, when milk is offered as the primary carrier of both vitamins A and D.
• Margarine fortification is mandatory or near-mandatory in most Western European countries.
• Breakfast cereals, infant formulas, some processed cheeses, some plant milks carry added retinyl palmitate or beta-carotene.
• Prenatal multivitamins universally contain vitamin A.
• Public dietary messaging — descended in part from a British Second World War disinformation campaign about RAF pilots eating carrots to hide the invention of radar — durably established carrots for eyesight as a folk certainty.

The moral capital of childhood blindness in the tiers monde is used to justify a fortification infrastructure in populations where clinical deficiency is rare. The rhetorical move is never made explicitly, but it is the ambient logic: since children are going blind in Bangladesh, your milk in Montréal is fortified with vitamin A.

Three facts systematically underdiscussed in this framework:

• Beta-carotene is not retinol. Conversion in the small intestine depends on BCMO1 enzyme activity, which is highly polymorphic; on adequate dietary fat (in absence of which carotenoids do not absorb); and on zinc status. A material fraction of the population converts beta-carotene very poorly. This weakens the “eat carrots” message but strengthens the case for the industrial fortificant — pre-formed retinyl palmitate — which the food industry supplies.
• Retinol is teratogenic in excess during pregnancy. Cumulative intake from fortified dairy, fortified margarine, fortified cereals, and multivitamin supplementation can easily approach the teratogenic threshold documented by Rothman et al. (NEJM 1995). This risk is structurally undercommunicated.
• The CARET and ATBC trials (1994) demonstrated that beta-carotene supplementation in smokers increased lung cancer incidence. A major epistemic reversal that should have forced a global reconsideration of the “antioxidants are protective” narrative. It produced no equivalent recalibration of the fortification framework.

Vitamin A is the case that closes the typology: an industry aligned so completely with a nutrient that it can circulate its product universally without needing the medical system to test anyone. The test-less nutrient is the industry’s dream — no measurement to disconfirm the claim, no threshold to defend, no ceiling to respect.

What is missing tells us everything

The mirror image of the five cases above is a group of nutrients whose biological importance is at least as well established, whose deficiencies are widespread, and whose testing and fortification infrastructure is almost entirely absent. This group is not an arbitrary list. It is a map of the food industries that do not exist.

• Magnesium. Primary dietary sources are unrefined whole grains, legumes, nuts, seeds, dark leafy greens, dark chocolate. The industrial refining of grain destroys magnesium, and no country requires mandatory Mg fortification of refined flour — though the case for it is arguably stronger than for many nutrients that are fortified. There is no dominant Mg food industry. Serum Mg, the test that is ordered, reflects less than 1% of body Mg and is structurally blind to intracellular depletion. Erythrocyte Mg, the better test, is not routine.
• Potassium. Primary sources are fruits, vegetables, legumes, tubers — the most diffuse and least industrially organised food category. The produce lobby exists but has none of dairy’s or milling’s political weight. Twenty-four-hour urinary potassium is the accepted field marker of adequacy and is not on any routine panel in ambulatory adult medicine.
• Vitamin K2 (MK-4, MK-7). Sources are contre-culturels to the modern industrial food system: natto, aged and mould-ripened cheeses, animal livers, egg yolks from pasture-raised birds. No mainstream industrial constituency. No routine test. Yet K2 activates osteocalcin — directing calcium into bone rather than soft tissue — and its deficiency probably accounts for much of the vascular calcification associated with the calcium-supplement cardiovascular signal above.
• Functional B12 — holotranscobalamin (active B12), methylmalonic acid, homocysteine. The functional markers would reveal deficiencies masked by fortificant folic acid and by the widespread use of gastric acid suppression drugs (PPIs, H2 blockers). Not routine. The pharmaceutical industry has an active interest in the invisibility of this deficiency, since PPI use is one of its largest ambulatory markets.
• Omega-3 (RBC Omega-3 Index; see Omega-3). Fish oil is a real industry but small and fragmented. Countervailing pressure comes from the industrial seed-oil industry (soybean, corn, sunflower, canola), which has a direct interest in the omega-6-to-omega-3 ratio remaining an invisible variable.
• Zinc, selenium, iodine (in Occident), boron, choline. No dedicated food industries of comparable clout; not on the routine panel.
• Riboflavin (B2), thiamine (B1), the vitamin E family beyond alpha-tocopherol. Fortified in various forms but not tested with functional markers (EGRAC, ETKAC, gamma- and delta-tocopherol) in general practice.

These are precisely the nutrients whose depletion is documented in the founding clinical cases of the physiological rights framework. They are not obscure. They are systemic. They are unmeasured because there is no economic constituency organised to demand that they be measured.

What the rights framework demands

The physiological rights framework does not treat the current menu of nutrient tests as a neutral technical fact. It treats it as a map of industrial alignments and political silences. Which means:

1. The right to physiological measurement cannot be delegated to the constellation of tests that food industries have found profitable to promote. The map is not the territory. The unmeasured nutrient is not the unimportant nutrient.
2. Iron is the demonstration that a proper multi-marker nutrient panel is technically feasible — has been technically feasible for over a century — when the political-economic conditions align. The obstacle to a functioning Mg panel, K panel, K2 panel, functional B12 panel, Omega-3 Index panel, is nowhere technical. It is that no constituency of iron’s weight has organised itself around them.
3. Fortification is not the answer, and the fortification framework is not neutral. Folic acid fortification masked B12 deficiency for two decades and is defended not because the harm is disproven but because reopening the debate threatens an industry. Universal vitamin A fortification circulates a product without ever measuring its effect on the individual body — a structural evasion of physiological verifiability.
4. The DRI/RDA numbers are not settled science. They are the outputs of committees whose composition is subject to industrial capture. When the North American calcium DRI is roughly double the WHO’s, when refined flour is fortified with iron but not magnesium in populations where magnesium depletion is at least as prevalent as iron depletion, when reference ranges for serum Mg have been challenged by the MaGNet international network for a decade without institutional response — these are political facts, not technical ones.
5. The named right. Every person has the right to have their essential physiological parameters tested — not just the ones the food industry has found profitable to promote. Denial of this — through structural absence of the test, through unreimbursement, through a specialty gate — is a violation of a physiological right. It is not less serious because the missing test is unfamiliar.

A closing observation

The medical system tells its patients that a bloodwork panel represents a state-of-the-art assessment of what is knowable about their body. It does not. It represents the intersection of what is technically feasible, what is reimbursable, what a specialty has decided to defend, and — running through and shaping all three — which food industries have organised themselves around which molecules over the past century.

The pattern is not evenly distributed. Iron sits inside it honestly, because the biology forced the medical system to develop a proper multi-marker panel and history preceded industry. Vitamin D sits inside it as a degraded test defending a fortification chain. Folate sits inside it as a genuine public health victory with a documented shadow allowed to remain in shadow. Calcium sits inside it as a test that measures the wrong thing, whose universality provides silent authority to an industrial infrastructure the biology does not, in fact, support. Vitamin A sits inside it as an industry that circulates its product globally without ever asking the individual body what has happened to it. Magnesium, potassium, K2, functional B12, omega-3, zinc, iodine sit outside it, in the space of the unmeasured — not because they matter less, but because no constituency has organised itself to demand that they be measured.

The right to physiological integrity is the right to a map drawn against the actual shape of the body’s needs — not against the shape of the industries that have grown up alongside it. Redrawing that map is one of the things this project is for.